spacer
home > pmps > spring 2017 > new thinking
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

New Thinking

When it comes to complacency, Albert Einstein once remarked: “If you always do what you always did, you will always get what you always got.” This very principle applies in healthcare and for today’s seven billion global consumers, who are living longer, have better access to quality care and are demanding more choices, greater convenience and improved outcomes.

It is an evolving paradigm, and delivering sophisticated, high-value pharmaceuticals to emerging markets will require continuous new thinking. The same supply chain issues will continue to pose steady challenges – cost and compliance chief among them – but leveraging cold chain innovations will produce significant gains in years to come.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Jan Denecker is responsible for executing UPS’s healthcare strategy in Europe. He joined the company in 2011 as Marketing Manager of Healthcare and led the launch of the department in Europe. In 2014, Jan was appointed Marketing Manager of Belgium and Luxembourg, responsible for business planning, revenue management, marketing and communications in both countries. He holds a Master’s degree in Law from the Université catholique de Louvain, Belgium, and a Master’s degree in Business Administration from the Vlerick School of Management, Belgium.
spacer
Jan Denecker
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Kloeckner Pentaplast Announces Plans for New Lamination Facility


More info >>

White Papers

Running Better Trials Taking an Intelligent Monitoring Approach

Bioclinica

When it comes to implementing a risk-based monitoring program, it is not just about reducing monitoring visits and doing less Source Document Verification (SDV). It’s about bringing together your people, a solid process, and the right technology to run a better trial. Success with risk-based monitoring requires the ability to make sense of the thousands, if not millions, of data points captured by multiple disparate sources in a clinical trial. With the sheer volume of data generated on a daily basis comes complexity. How does one make sense of it all? Information overload burdens even the most experienced study teams who struggle to understand which data matters most and what it means.
More info >>

 
Industry Events

6th Annual Cancer Vaccines Conference

27-28 September 2017, Copthorne Tara Hotel, London UK

Cancer Vaccines 2017: Overcoming hurdles to cancer immune response: Cell therapies, vaccine development and combination therapies. SMi Group is thrilled to present the 6th annual Cancer Vaccines conference, taking place on 27th & 28th September 2017 in Central London, UK. Overcoming hurdles to cancer immune response: Cell therapies, vaccine development and combination therapies.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement